Unlock Unmatched Success with Xentria Inc.'s Tailored Solutions

In addition, Victoria is the General Counsel & Corporate Secretary of Xentria, Inc. a biotech company focused on novel biologics and biosimilars, which was ... Xentria is a biotech company focused on developing novel therapeutics to address unmet clinical needs. Ensayos clínicos para Xentria, Inc.. Registro de ensayos clínicos. ICH GCP. Xentria is is an innovative biopharmaceutics company whose primary focus is to build an expansive product pipeline of therapeutics to address. Xentria, Inc. has partnered with the Foundation for Sarcoidosis Research for the XTMAB16 Study. XTMAB-16 is a tumor necrosis factor (TNF) inhibitor that aims to ... CHICAGO, IL June 27, 2023: Xentria Inc., a clinical-stage biotherapeutics company focused on developing therapeutics to address unmet clinical needs, ... Operator of a biopharmaceutic company intended to develop drugs to help solve medical unmet needs through meaningful patient engagement and novel scientific ... Gale OneFile includes U.S. Clinical Trial: Xentria, Inc. Listed a New Clinica by . Click to explore. Sponsor: Xentria, Inc. Overall Status: Active - Recruiting. Phase. 1/2. Condition. Sarcoidosis. Lung Disease. Treatment. XTMAB-16 or Placebo ... Established in 2020, Xentria works across biopharmaceutics communities creating innovative and authentic collaborations and partnerships ...